Scientists identify mechanisms in aspirin that help protect against cancer

June 1, 2012
Scientists identify mechanisms in aspirin that help protect against cancer
Tracks/footprints of white blood cells as they find early cancer cells (green) in the zebrafish larvae

(Medical Xpress) -- Recent clinical studies have indicated that long-term usage of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin can significantly reduce the risk of various cancers — some up to 30 per cent.  New findings, published today in Current Biology, provides fresh evidence into their protective properties.

Until now, the processes that underpin these protective effects were unclear but researchers from the Universities of Bristol and Sheffield have now identified how long-term use and low doses of may help to stave off cancer. 

Using translucent zebrafish larvae the researchers were able to visualise how white interact with the early cancer cell formation as they arise in tissues. Previous studies have shown that are less likely to divide if the white blood cells can be prevented from contacting the precursor cancer cells, suggesting that white blood cells – the immune cells – have the ability to promote disease by providing some kind of growth signal.

Lead author, Dr Yi Feng from Bristol's School of Biochemistry, found that these white blood cells, whose normal role is to fight off infections, supply the cancer cells with essential survival factors and identified one of these key factors as prostaglandin – PGE2.  If the immune cells are genetically deleted then the cancer cells cannot grow but they begin growing again if the researchers feed them PGE2. 

The results show that at least in part, taking drugs like , which are generally taken for cardiovascular problems, prevent the development of cancer by starving the cancer cells of this source of white blood cell early-growth support.

Paul Martin, Professor of Cell Biology at the University of Bristol’s Schools of Biochemistry and Physiology and Pharmacology and senior author of this study, said: “These findings are important as they help explain the underlying cellular processes at work which could be used to develop potential new therapies for eliminating early-stage cancer in humans.”

Explore further: Scientists expose important new weak spot in cancer cells

More information: The Wellcome Trust funded study, entitled Live Imaging of Tumor Initiation in Zebrafish Larvae Reveals a Trophic Role for Leukocyte-Derived PGE2 is published today [31 May] in Current Biology.

Related Stories

Scientists expose important new weak spot in cancer cells

December 5, 2011

(Medical Xpress) -- Cancer Research UK scientists have discovered that cancer cells can ‘bag up and bin’ a toxic protein to cheat death – revealing a new Achilles heel in cancer cells that could be targeted ...

Prostate cancer early warning protein detected

May 31, 2012

(Medical Xpress) -- Scientists at the University have discovered a protein, only present in prostate cancer cells, that could be used as a marker to detect early signs of the disease.     

Recommended for you

Researchers thwart cancer cells by triggering 'virus alert'

August 27, 2015

Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.